Muhamed Higazi

Title: Innovations by Muhamed Higazi in Hemostatic Disorders

Introduction

Muhamed Higazi is an accomplished inventor based in D.N. Shimshon, Israel. He has made significant contributions to the field of medical technology, particularly in the development of therapeutic products aimed at treating bleeding disorders. His innovative work focuses on human blood-derived products that have decreased fibrinolytic activity.

Latest Patents

Higazi holds a patent for "Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders." This invention provides therapeutic products with decreased fibrinolytic activity of t-PA-deficient and/or plasminogen-deficient blood products. The patent also includes compositions, kits, and methods for treating bleeding associated with hereditary or acquired bleeding disorders. Additionally, it offers an extracorporeal apparatus for blood or blood products plasmapheresis, aimed at preventing or treating bleeding disorders.

Career Highlights

Muhamed Higazi is associated with Plas-free Ltd., where he continues to work on innovative solutions for hemostatic disorders. His expertise in the field has led to advancements that can significantly improve patient outcomes.

Collaborations

Higazi collaborates with Abd Alrauf Hijazi, contributing to the development of new technologies and therapeutic approaches in the medical field.

Conclusion

Muhamed Higazi's work in developing blood-derived products with decreased fibrinolytic activity represents a significant advancement in treating hemostatic disorders. His contributions are poised to make a lasting impact on medical treatments for patients with bleeding disorders.